U.S. spot Bitcoin ETFs experienced a sharp reversal with $524.8 million in inflows on October 21 followed by $635.6 million in outflows on October 22 and another $137.9 million withdrawn on October 23. Despite these withdrawals, the net inflow for the week from October 19 to 23 remained positive at $301.2 million. Major funds like BlackRock's IBIT and Fidelity's FBTC accounted for most of the outflows. The SEC's approval of in-kind Bitcoin redemptions since July 2025 means ETF withdrawals do not always trigger immediate Bitcoin sales, complicating the direct impact on Bitcoin's spot price, which traded around $80,000 to $82,000 during this period. Investors should watch upcoming fund flow data and Bitcoin price movements to gauge ongoing market sentiment.
Bitcoin ETFs saw a net inflow of $301.2 million for the week ending October 23, despite a sharp reversal with $635.6 million in outflows on October 22. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 25, 2026 16:21 WIB: out of 50 major cryptocurrencies, 6 rose and 41 fell today. Notable movers include DOT at Rp18.332 with a 1-day change of -4.17% and Pluang order activity showing 58% Sell / 42% Buy, THETA at Rp3.350 down 4.07% with 0% Sell / 100% Buy, and AAVE at Rp2.444.111 down 4.01% with 2% Sell / 98% Buy.
Ethereum prices fell to the $2,350-$2,380 range following large sell-offs by BitMEX co-founder Arthur Hayes, who liquidated Ethereum and DeFi assets ahead of the Federal Reserve's critical policy meeting. This move reflects institutional caution amid...
Stellar Lumens (XLM) was trading at $0.1679 on October 25, slightly below the forecasted target of $0.174 set for October 27. This represents a 1.66% increase expected by the forecast, but the current price is down 1.08% over the past 24 hours. Techn...
The SEC has approved the listing of six triple-leveraged ETFs from Volatility Shares on the Cboe BZX Exchange, including 3x Bitcoin and 3x Ether ETFs. This marks the first US regulatory approval for crypto products with such high leverage. However, t...
Regeneron's Libtayo (cemiplimab) demonstrates a growing overall survival benefit for high-risk cutaneous squamous cell carcinoma (CSCC) patients after nearly four years of follow-up in the Phase 3 C-POST trial. The data reveal a 37% reduction in deat...
Galaxy Research discovered an unknown user embedding a short poem 28 times into the Bitcoin blockchain over 12 days. The poem, stored in transaction data exceeding usual size limits, has unclear motives. Researchers ruled out typical money laundering...
